庄志刚 主任医师，副教授
硕士招生类型：学术型；专业型
硕士招生专业：外科学（普外科）
博士招生类型：
博士招生专业：
所在院系：附属第一妇婴保健院
联系方式：zhuang_zg@163.com
课题组链接：
研究方向
主要任职
科研业绩

乳腺肿瘤学Breast Oncology ；外科Surgery


卫生部百万妇女乳腺癌普查专家委员会副主任委员，中国抗癌协会乳腺癌专业委员会委员，中国妇幼协会乳腺病专业委员会委员，上海市中西医结合协会乳腺病专业委员会委员，同济大学学报编委，美国临床肿瘤学会（American Society of Clinical Oncology, ASCO）正式会员，中华医学会会员。
The ministry of health of millions of women breast census committee member, deputy director of the expert committee committee member of China association of breast cancer, the committee member of China association of women's and children's mammary gland disease, the Shanghai combine traditional Chinese and western medicine association professional committee of mammary gland disease, tongji university journal editors, the American Society of Clinical Oncology (American Society of Clinical Oncology, ASCO) formal member, member of the Chinese medical association



1. 主持上海市自然科学基金、上海市科委医学引导类、上海市卫生局课题等多项科学研究计划项目。参与上海市科委重点医学领域项目。主编《乳房常见病咨询》、《乳房癌咨询》，参编《New Challenges in Communication with Cancer Patients》。长期从事肿瘤外科工作,尤其是乳腺癌及软组织肿瘤的诊治工作。以第一或通讯作者发表SCI论文十余篇。先后到美国UCLA和·奥地利AKH医院研修
2. Presided over by the natural science foundation, Shanghai municipal science and technology commission of Shanghai medical guide, Shanghai municipal bureau of health issues such as many scientific research projects.Participate in science and technology commission of Shanghai key medical field project.Editor in chief of the breast diseases consultation, the breast Cancer consultation, participated in the New Challenges in the Communication with Cancer Patients ".Long-term work in the surgical oncology, especially for breast cancer and soft tissue tumor diagnosis and treatment work.In the first or corresponding author SCI papers published more than 10 articles 。UCLA and · Austria AKH hospital successively to the study。
近期发表文章：
1.Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43 Eur Rev Med Pharmacol Sci. 2015 Jun;19(11):2091-104.
2.Advances and Perspectives in Nanoprobes for Non-invasive Lymph Node Mapping. Nanomedicine. 2015;10(6):1019-36
3..Liver kinase B1 enhances chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells.Oncol Lett.2014 Nov;8(5):2086-2092.
4..Fluorescence tomographic imaging of sentinel lymph node using near-infrared emitting bioreducible dextran nanogels.International Journal of Nanomedicine.2014 Dec 4;9:5667-82.
5..Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis. Int J Clin Exp Pathol. 2014 Sep 15;7(10):6419-29.
6..Preoperative measurement of breast cancer overestimates tumor size compared to pathological measurement. PLoS One. 2014 Jan 29;9(1):e86676.
7..LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway. PLoS One. 2013 Jul 4;8(7):e67431.